MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 139481-59-7
MCE 国际站:Candesartan
产品活性:Candesartan (CV 11974) 是一种血管紧张素 II AT1-受体阻滞剂和 PPAR-γ 激动剂,具有口服活性。Candesartan 具有强效和持久的抗高血压作用。Candesartan 可用于高血压、慢性心力衰竭(CHF)和创伤性脑损伤(TBI)的研究。
研究领域:GPCR/G Protein | Vitamin D Related/Nuclear Receptor | Cell Cycle/DNA Damage
作用靶点:Angiotensin Receptor | PPAR
In Vivo: Candesartan (i.p.; 1?mg/kg/day; continuously for 1, 3 or 28 dpi) has neuroprotective effect, reducing neuronal injury, decreasing lesion volume and microglial activation, protecting CBF and improving functional behavior in a mouse model of TBI.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | GPCR/G Protein Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | CNS-Penetrant Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | Endocrinology Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Neuroprotective Compound Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Transcription Factor-Targeted Library | Lipid Metabolism Compound Library | Rare Diseases Drug Library | Antidepressant Compound Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Nuclear Receptor Compound Library | Non-steroidal Anti-Inflammatory Compound Library | Osteogenesis Compound Library | Cancer Stem Cells Compound Library | Off-patent Drug Library | Mitochondrial Protection Compound Library | Antihypertensive Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | LY518674 | Irbesartan hydrochloride | Bocidelpar | Retinoic acid | 5-Aminosalicylic Acid-d3 hydrochloride | Dehydro Olmesartan | Losartan Carboxylic Acid | A81988 | Naveglitazar | Eprosartan | Ertiprotafib | ATRA-biotin | Convallatoxin | MHY908 | Angiotensin III, human, mouse TFA | (Sar1,Ile4,8)-Angiotensin II | Losartan-d3 Carboxylic Acid | Ciprofibrate | Irbesartan-d4 | MK-886 | Saralasin acetate hydrate | Allisartan isoproxil | TRV-120027 | Bezafibrate-d4 | Mifobate | Mepixetil | Losartan carboxylic acid-d4 hydrochloride | Angiotensin amide | 10-Nitrolinoleic acid
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。